Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma.

Read more: https://medicalxpress.com/news/2026-08-immune-car-cell-therapy-pediatric.html